Company Filing History:
Years Active: 2014
Title: The Innovative Journey of David Nathan Zalatan
Introduction: David Nathan Zalatan is a prominent inventor based in Palo Alto, California. With a successful career in the pharmaceutical industry, he has contributed to significant advancements through his inventions, holding a total of two patents.
Latest Patents: David's most recent patents focus on polycyclic compounds as lysophosphatidic acid receptor antagonists. These inventions describe compounds that act as antagonists of lysophosphatidic receptors. Alongside these compounds, he has developed pharmaceutical compositions and medicaments that incorporate these innovations. The methods outlined within these patents enable the use of such antagonists, both alone and in combination with other compounds, to treat conditions or diseases that are dependent on or mediated by lysophosphatidic acid (LPA).
Career Highlights: David Nathan Zalatan is currently employed at Amira Pharmaceuticals, Inc., where he continues to drive innovation in the field of pharmacology. His work is characterized by a focus on developing advanced therapeutic solutions that address complex biological pathways.
Collaborations: Throughout his career, David has collaborated with talented colleagues including Ryan Christopher Clark and Brian Andrew Stearns. These partnerships have fostered an environment of creativity and innovation, essential for the development of groundbreaking pharmaceutical products.
Conclusion: David Nathan Zalatan is a distinguished inventor whose contributions to the field of pharmaceuticals have the potential to significantly impact the treatment of various diseases. His patent work, particularly in the area of lysophosphatidic acid receptor antagonism, showcases his dedication to advancing medical science and improving patient outcomes.